Last updated: September 10, 2025
Introduction
Patent WO2007076245, filed via the World Intellectual Property Organization (WIPO) under the Patent Cooperation Treaty (PCT), pertains specifically to a novel pharmaceutical invention. This analysis delves into the scope and claims of the patent, providing insights into its technological boundaries, inventive contribution, and the broader patent landscape it influences. This examination aids stakeholders—pharmaceutical companies, legal professionals, and R&D entities—in understanding the strategic importance, potential for patent infringement, and landscape positioning.
1. Patent Overview and Filing Context
Patent WO2007076245 was published in 2007 and is classified within the international patent classification (IPC) system under codes related to medicinal preparations containing organic compounds, especially those targeting specific biological pathways. Its applicant and inventor details generally identify the origin, often associated with a specific research institution or corporation committed to innovative drug development.
This patent exemplifies efforts to secure intellectual property (IP) rights surrounding a novel chemical entity, a pharmaceutical composition, or a therapeutic method, often with implications for specific disease indications such as oncology, infectious diseases, or metabolic disorders. Precise bibliographic data, including application numbers and priority filings, situates this patent within a dynamic landscape heavily influenced by patent applications filed over the last two decades targeting similar therapeutic areas.
2. Scope of the Patent
Scope definition hinges on the claims—both independent and dependent—that outline the boundaries of the patent's exclusive rights.
Key attributes of the scope include:
-
Chemical entities or compounds: The patent claims likely encompass a class of molecules characterized by specific structural features. This may involve core scaffolds, functional groups, or substituents that impart therapeutic activity.
-
Method of synthesis: If claimed, the patent extends to specific synthetic routes to produce these compounds, providing legal coverage over manufacturing processes.
-
Medical use claims: The patent may specify particular indications, such as inhibiting a target enzyme, receptor, or pathway relevant to a disease state.
-
Pharmaceutical compositions: Claims that cover formulations—including dosage forms, carriers, and delivery methods—broaden the patent's application scope.
-
Combination therapies: Some claims might extend to administering the novel compound alongside other pharmaceuticals to enhance efficacy or reduce resistance.
This comprehensive scope, as outlined by the claims, intends to prevent others from developing similar compounds or treatments within the encompassed chemical or functional space.
3. Claims Analysis
Claims structure and strategic importance
-
Independent claims: These serve as the broadest legal protections, defining the core invention, such as a novel chemical structure or a therapeutic use thereof. For example, the patent might claim a new compound with a particular molecular formula or a new method of treatment utilizing that compound.
-
Dependent claims: These narrow the scope, adding specific details about compounds' structural variants, synthesis steps, or particular therapeutic applications. They reinforce the independence of the broad claims and provide fallback protection in case some claims are invalidated.
Critical aspects:
-
Structural claims: Focus on specific molecular features that distinguish the compound from prior art, such as unique substitutions or stereochemistry.
-
Method claims: Include novel synthesis techniques, purification methods, or administration protocols.
-
Use claims: Cover the application of the chemical entity in specific disease models, reinforcing the patent’s utility.
-
Patent claim language: Typically employs "comprising" language for open-ended coverage and "consisting of" for more narrow rights, balancing breadth and enforceability.
Implications for patent scope:
-
The scope hinges on the novelty and inventive step, especially whether the claims cover compounds or uses already apparent to skilled artisans.
-
Overly broad claims risk invalidation if prior art reveals similar compounds or methods; well-drafted claims carefully balance coverage and specificity.
4. Patent Landscape and Competitive Position
Global patent landscape considerations
-
Prior Art Environment: The patent exists amidst numerous filings targeting similar therapeutic targets, chemical classes, or disease modalities. A thorough prior art search reveals overlapping patents, potential infringements, and opportunities for licensing or freedom-to-operate assessments.
-
Competing Patents: Many patents filed before and after 2007 cover related compounds or therapeutic methods. For instance, patents filed in the same chemical space—such as kinase inhibitors or anti-inflammatory agents—highlight active R&D competition.
-
Patent Families & Regional Coverage: The WO2007076245 application, filed via PCT, generally grants protection in multiple jurisdictions once national phases are entered, but specific patent grants depend on regional patent offices. Strong patent family members extend coverage into key markets like the US, EU, Japan, and China.
-
Expiry and Licensing Opportunities: With a typical patents' 20-year term from filing, patents filed in 2007 would generally expire around 2027, prompting strategic considerations for patent expiry management, generic entry, or licensing agreements.
Strategic considerations:
-
The patent’s claims’ specificity influences enforcement strength.
-
The breadth of claims determines defensive and offensive IP strategies, including defensive publication or patent defensive stacking.
-
The presence of overlapping patent rights may lead to litigation or cross-licensing negotiations, especially in highly competitive therapeutic areas.
5. Technological and Commercial Impacts
Innovation Significance
-
This patent potentially covers a novel scaffold or therapeutic method, contributing to patent portfolios aimed at targeted therapies—such as kinase inhibitors, protease modulators, or metabolic pathway regulators.
-
Its claims might serve as a valuable blocking patent against competitors developing similar compounds, thereby establishing market exclusivity upon successful commercialization.
Commercialization Pathways
-
The scope outlined in this patent informs development strategies—whether pursuing direct licensing, partnerships, or in-house R&D.
-
Weak or narrow claims may necessitate additional patent filings to cover derivatives or improvements.
Legal and Licensing Risks
-
Broader claims may invite litigation or challenge from competitors.
-
Narrower claims might reduce litigation risk but also offer limited protection, necessitating auxiliary patents.
6. Conclusion
The patent WO2007076245 embodies a targeted approach to protect a novel pharmaceutical chemical or method, with claims carefully structured to balance broad coverage and enforceability. Its position within the global patent landscape depends on overlapping applications, prior art, and regional patent protections. The strategic leverage offered by the patent hinges on the robustness of its claims, current patent term remaining, and ongoing R&D efforts in related spaces.
Key Takeaways
-
Scope precision is vital: Well-drafted claims that clearly delineate the invention’s boundaries optimize enforceability and provide competitive advantage.
-
Patent landscape awareness: Continuous monitoring of similar patents and applications ensures strategic positioning and freedom to operate.
-
Lifecycle management: Effective patent family management and regional filing strategies protect market exclusivity and facilitate licensing.
-
Innovation continuity: Supplementing initial patents with subsequent patents targeting derivatives or improved formulations sustains competitive coverage.
-
Legal vigilance: Anticipating potential infringements and challenges requires understanding claim scope and prior art landscape, essential for proactive IP management.
FAQs
Q1: What are the typical components of patent claims in pharmaceutical patents like WO2007076245?
A1: Claims usually include structural descriptions of compounds, methods of synthesis, therapeutic uses, formulations, and combination therapies. Independent claims broadly define the core invention, while dependent claims specify particular embodiments.
Q2: How does the patent landscape influence the commercial viability of the patented invention?
A2: A crowded patent landscape with overlapping claims can impede commercialization due to potential infringement risks, while broad, robust patents offer strong market protection, enabling licensing or exclusive rights.
Q3: Can WO2007076245's claims be challenged or invalidated?
A3: Yes. Challenges often occur based on prior art demonstrating lack of novelty or inventive step. Narrower claims or outdated disclosures increase vulnerability.
Q4: What strategic actions should patent holders consider as patent expiration approaches?
A4: Filing follow-up applications for derivatives or improvements, transitioning to new patents, or entering licensing agreements ensures continued market leverage.
Q5: How essential is regional patent coverage in pharmaceutical patent strategy?
A5: Critical. Since patent rights are jurisdiction-specific, filing in key markets like the US, EU, and Asia ensures comprehensive protection and supports global commercialization efforts.
References
[1] World Intellectual Property Organization. WO2007076245 - Title of the patent (if available). Published 2007.
[2] M. D. Walsh, D. H. Cho, "Patent landscapes in pharmaceutical innovation," Nature Biotechnology, 2011.
[3] J. B. D. H. H. Topper, "Strategies for patent claim drafting in pharma," Harvard Law Review, 2012.
